Garath. Do you know why ADO has not decided to design and make some of our own laterial flow tests and then licence out for royalties? Similar to what was planned for covid test but without the reader. A Parma could worry about approvals and packaging etc as part of the agreement.
i believe this could be done quickly and inexpensively. Take back control of our destiny as well as assisting other partners. ADO could potentially have dozens of "test samples" completed within 12 months ready for approvals and licencing. Start with a quantitative pregendy test. Should be pretty easy and quickly profitable to complete for our team.
This waiting for other companies to decide for EVERY part of ADO future is wearing very thin.
ADO Price at posting:
1.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)